Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 04 - 12    symbols : LLY    save search

Innovent and Lilly Release Phase 3 Results of TYVYT® (Sintilimab Injection) as a Second-Line Treatment for Squamous Non-Small Cell Lung Cancer at AACR Annual Meeting 2021
Published: 2021-04-12 (Crawled : 01:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%

treatment lung cancer injection results cancer phase 3
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-04-12 (Crawled : 00:00) - fda.gov
PFE A | $26.0 2.4% -0.15% 38M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 1.52% C: 1.34%
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%
BMY | $48.93 1.3% 0.0% 10M twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.39% C: 0.26%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.7% C: 0.4%
XERS | $1.73 -1.7% -1.73% 2M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.12% C: -6.65%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.12% C: -0.69%
REGN | $896.27 0.26% 0.25% 500K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.0% C: -1.86%
OTIC | $0.077 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.9% C: -0.45%
OMER | $3.045 -5.14% -5.42% 390K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -7.13%
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.08% C: -0.61%
BCRX | $4.44 -1.33% -1.35% 4.7M twitter stocktwits trandingview |
Health Technology
| | O: -0.59% H: 0.1% C: -6.4%
AMGN | $269.03 2.39% 2.33% 3.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 0.6% C: 0.17%


Clinical Catch-Up: April 5-9
Published: 2021-04-12 (Crawled : 14:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%


Lilly modified COVID-19 purchase agreement for bamlanivimab alone with the U.S. government and is focusing on supply of bamlanivimab and etesevimab together
Published: 2021-04-12 (Crawled : 13:15) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.57% H: 0.28% C: -0.88%

covid
Gainers vs Losers
67% 33%

Top 10 Gainers
GBR | $1.42 31.48% 11.27% 990K twitter stocktwits trandingview |
Energy Minerals

KUKE | $2.88 2.49% 7.64% 360K twitter stocktwits trandingview |

MPLN | $0.6502 -11.74% 4.51% 2.2M twitter stocktwits trandingview |
Finance

CXM 4 | $11.34 -0.44% 4.27% 1.7M twitter stocktwits trandingview |
Information

PVL 4 | $1.47 -0.68% 4.08% 77K twitter stocktwits trandingview |
Energy Minerals

RNR 4 | $224.74 0.85% 3.52% 310K twitter stocktwits trandingview |
Finance

PZG | $0.4431 0.48% 2.91% 150K twitter stocktwits trandingview |
Non-Energy Minerals

DBRG | $17.3 0.06% 1.97% 1.2M twitter stocktwits trandingview |
Finance and Insurance

HYLN 4 | $1.29 -2.27% 1.55% 680K twitter stocktwits trandingview |
Producer Manufacturing

RC | $8.62 1.77% 0.81% 1M twitter stocktwits trandingview |
Finance


Your saved searches
Save your searches and get alerts when important news are released.